Neoadjuvant Prehabilitation Therapy for Locally Advanced Non-small-Cell Lung Cancer: Optimizing Outcomes throughout the Trajectory of Care

被引：0
作者：
Schmid, S. [1 ]
Minnella, E. M. [2 ]
Pilon, Y. [2 ]
Rokah, M. [2 ]
Rayes, R. [2 ]
Najmeh, S. [2 ]
Cools-Lartigue, J. [2 ]
Ferri, L. [2 ]
Mulder, D. [2 ]
Sirois, C. [2 ]
Owen, S. [2 ]
Shieh, B. [2 ]
Ofiara, L. [2 ]
Wong, A. [2 ]
Sud, S. [3 ]
Baldini, G. [2 ]
Carli, F. [2 ]
Spicer, J. [2 ]
机构：
[1] Univ Freiburg, Med Ctr, Freiburg, Germany
[2] McGill Univ, Hlth Ctr, Montreal, PQ, Canada
[3] Ctr Integre Sante & Serv Sociaux Outaouais, Gatineau, PQ, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期
关键词：
Prehabilitation; neoadjuvant therapy; exercise program;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP05.02-01
引用
收藏
页码：S289 / S289
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant strategies for non-small cell lung cancer
    van Zandwijk, N
    LUNG CANCER, 2001, 34 : S145 - S150
  • [32] Neoadjuvant chemotherapy for non-small cell lung cancer
    Pinder-Schenck, M.
    Bepler, G.
    MINERVA CHIRURGICA, 2009, 64 (06) : 611 - 628
  • [33] Sarcopenia is related to poor prognosis in patients after trimodality therapy for locally advanced non-small cell lung cancer
    Katsui, Kuniaki
    Ogata, Takeshi
    Watanabe, Kenta
    Yoshio, Kotaro
    Kuroda, Masahiro
    Yamane, Masaomi
    Hiraki, Takao
    Kiura, Katsuyuki
    Toyooka, Shinichi
    Kanazawa, Susumu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (08) : 1450 - 1460
  • [34] Sarcopenia is related to poor prognosis in patients after trimodality therapy for locally advanced non-small cell lung cancer
    Kuniaki Katsui
    Takeshi Ogata
    Kenta Watanabe
    Kotaro Yoshio
    Masahiro Kuroda
    Masaomi Yamane
    Takao Hiraki
    Katsuyuki Kiura
    Shinichi Toyooka
    Susumu Kanazawa
    International Journal of Clinical Oncology, 2021, 26 : 1450 - 1460
  • [35] Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Surgical Outcomes in a Regionalized Pulmonary Oncology Network
    Pilon, Y.
    Rokah, M.
    Rayes, R. F.
    Cools-Lartigue, J.
    Najmeh, S.
    Sirois, C.
    Mulder, D.
    Ferri, L.
    Abdulkarim, B.
    Ezer, N.
    Fraser, R.
    Camilleri-Broet, S.
    Fiset, P. -O.
    Wong, A.
    Sud, S.
    Langleben, A.
    Agulnik, J.
    Pepe, C.
    Shieh, B.
    Hirsh, V.
    Ofiara, L.
    Owen, S.
    Spicer, J. D.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S290 - S290
  • [36] Grading of tumor regression in non-small cell lung cancer after neoadjuvant therapy
    Junker, K
    Thomas, M
    Schulmann, K
    Klinke, V
    Bosse, U
    Muller, KM
    PATHOLOGE, 1997, 18 (02): : 131 - 140
  • [37] NEOSTAR trial and the current status of neoadjuvant therapy in non-small cell lung cancer
    Sepesi, Boris
    Mehran, Reza
    Spicer, Jonathan
    Cascone, Tina
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 167 (06) : 1936 - 1942
  • [38] Current surgical treatment of non-small-cell lung cancer
    Van Schil, Paul E.
    Hendriks, Jeroen M.
    Hertoghs, Marjan
    Lauwers, Patrick
    Choong, Cliff
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (10) : 1577 - 1585
  • [39] Perioperative immunotherapy for resectable non-small-cell lung cancer
    Xiaodong Yang
    Dongliang Bian
    Jie Yang
    Liang Duan
    Haifeng Wang
    Deping Zhao
    Gening Jiang
    Yuming Zhu
    Peng Zhang
    Clinical Cancer Bulletin, 3 (1):
  • [40] Effectiveness of neoadjuvant chemotherapy on the survival outcomes of patients with resectable non-small-cell lung cancer: A meta-analysis of randomized controlled trials
    Zhang, Yunfeng
    Hu, Xiayun
    Liu, Dapeng
    Wang, Rui
    Sun, Xin
    Peng, Ziyang
    Ren, Hong
    Du, Ning
    SURGICAL ONCOLOGY-OXFORD, 2021, 38
12345